Aryl isocyanide derivative for one-pot synthesis of purification-free 99m Tc-labeled hexavalent targeting probe

Tc-labeled hexavalent probes can be readily synthesized by the coordination of six equivalent isocyanide ligands towards Tc , and alkyl isocyanide ligands have been extensively used for preparing such probes. However, high ligand concentration (>1 mM) is generally required due to their insufficie...

Full description

Saved in:
Bibliographic Details
Published inNuclear medicine and biology Vol. 86-87; p. 30
Main Authors Mizuno, Yuki, Komatsu, Nagiho, Uehara, Tomoya, Shimoda, Yuka, Kimura, Kohta, Arano, Yasushi, Akizawa, Hiromichi
Format Journal Article
LanguageEnglish
Published United States 16.05.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Tc-labeled hexavalent probes can be readily synthesized by the coordination of six equivalent isocyanide ligands towards Tc , and alkyl isocyanide ligands have been extensively used for preparing such probes. However, high ligand concentration (>1 mM) is generally required due to their insufficient coordination ability to Tc . In this study, we revealed that aryl isocyanide ligands, which have greater π-accepting ability compared with alkyl ones, provided Tc-labeled hexavalent probes in high radiochemical yields (>95%) even at low ligand concentration (50 μM). We applied this finding to the synthesis of a Tc-labeled hexavalent RGD probe, targeting integrin α β . This Tc-labeled probe was prepared in a 5 min reaction at ligand concentration of 50 μM, and exhibited high tumor localization in vivo without post-labeling purification. The present findings indicate that aryl isocyanide ligands would be a useful precursor to a variety of Tc-labeled hexavalent targeting probes for molecular imaging of saturable systems. Aryl isocyanide is a better precursor than alkyl isocyanide for preparing Tc-labeled hexavalent targeting probe. This work provides a straightforward method to prepare molecular imaging agents of high target uptake, which would facilitate nuclear medicine imaging in clinical settings.
ISSN:1872-9614